Abstract
Genomic analyses of Amycolatopsis orientalis ATCC 43491 strain, deposited as a vancomycin producer, revealed the presence of genetic loci for the production of at least 10 secondary metabolites other than vancomycin. One of these gene clusters, which contained a type I polyketide synthase, was predicted to direct the synthesis of novel class of compound, a glycosidic polyketide ECO-0501 (1). Screening of culture extracts for a compound with the predicted physicochemical properties of the product from this locus, led to the isolation of the 13-O-glucuronide of 13-hydroxy-2,12,14,16,22-pentamethyl-28-(N-methyl-guanidino)-octacosa-2,4,6,8,10,14,20,24-octaenoic acid (2-hydroxy-5-oxo-cyclopent-1-enyl)-amide (ECO-0501, 1). The structure, confirmed by spectral analyses including MS, and 1D and 2D NMR experiments, were in accord with that predicted by genomic analyses. ECO-0501 possessed strong antibacterial activity against a series of Gram-positive pathogens including several strains of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). ECO-0501 was chemically modified by esterification (1a~1c), N-acetylation (1d) and hydrogenation (1e) in order to explore structure activity relationships (SAR).
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Zazopoulos E, Huang K, Staffa A, Liu W, Bachmann BO, Nonaka K, Ahlert J, Thorson JS, Shen B, Farnet CM . A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 21: 187–190 ( 2003).
Zazopoulos E, Farnet CM . Improving drug discovery from Microorganisms. Natural Products: Drug Discovery and Therapeutic Medicine; Zhang, Demain eds., pp. 95–106 ( 2005)
McAlpine JB, Bachmann BO, Piraee M, Tremblay S, Alarco AM, Zazopoulos E, Farnet CM . Microbial genomics as a guide to drug discovery and structural elucidation: ECO-02301, a novel antifungal agent, as an example. J Nat Prod 68: 493–496 ( 2005)
Banskota AH, McAlpine JB, Sørensen D, Aouidate M, Piraee M, Alarco AM, Ōmura S, Shiomi K, Farnet CM, Zazopoulos E . Isolation and identification of three new 5-Alkenyl-3,3(2H)-furanones from two Streptomyces species using a genomic screening approach. J Antibiot 59: 168–176 ( 2006)
Sørensen D, McAlpine JB, Piraee M, Farnet CM, Zazopoulos E . Genome scanning technology reveals an antibacterial compound (ECO-0501) of a new structural class from the vancomycin-producer Amycolatopsis orientalis. 44th ICAAC: No. F-720a, Washington, DC ( 2004)
McAlpine JB, Zazopoulos E, Sørensen D, Piraee M, Ibrahim A, Aouidate M, Farnet CM . The power of genomic analysis in the discovery of novel secondary metabolites. 46th Annual Meeting of American Society of Pharmacognosy: No. O-21, Corvallis ( 2005)
Nakagawa A, Wu TS, Keller PJ, Lee JP, Ōmura S, Floss HG . Biosynthesis of asukamycin. Formation of the 2-aminocyclopentenol-3-one moiety. J Chem Soc Chem Commun 1985: 519–521 ( 1985)
Caffrey P . Conserved amino acid residues correlating with ketoreductase stereospecificity in modular polyketide synthases. Chembiochem 4: 654–657 ( 2003)
Block K, Pedersen C . Carbon 13 nuclear magnetic resonance spectroscopy of monosaccharides. In Advances in Carbohydrate Chemistry and Biochemistry, Vol. 41. Academic Press, New York, pp. 27–66 ( 1983)
Argoudelis AD, Baczynskyj L, Kuo MT, Laborde AL, Sebek OK, Truesdell SE, Shilliday FB . Arginomycin: production, isolation, characterization and structure. J Antibiot 11: 750–760 ( 1987)
Kanzaki H, Wada K, Nitoda T, Kawazu K . Novel bioactive oxazolomycin isomers by Streptomyces albus JA3453. Biosci Biotechnol Biochem 62: 438–442 ( 1998)
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Fifth Edition. (NCCLS document M7-A5, ISBN 1-56238-394-9; NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA)
Yamakawa T, Furumai T, Yoshida R, Igarashi Y . Clethramycin, a new inhibitor of pollen tube growth with antifungal activity from Streptomyces hygroscopicus TP-A0623 I. Screening, taxonomy, fermentation, isolation and biological properties. J Antibiot 56: 700–704 ( 2003)
Igarashi Y, Iwashita T, Fujita T, Naoki H, Yamakawa T, Yoshida R, Furumai T . Clethramycin, a new inhibitor of pollen tube growth with antifungal activity from Streptomyces hygroscopicus TP-A0623. II Physico-chemical properties and structure determination. J Antibiot 56: 705–708 ( 2003)
Clethramycin was isolated and identified independently at Ecopia Biosciences and correlated with its biosynthetic locus (data not shown)
Author information
Authors and Affiliations
Corresponding author
Additional information
References 3 and 4 are considered as Parts 1 and 2, respectively, of this series.
Rights and permissions
About this article
Cite this article
Banskota, A., McAlpine, J., Sørensen, D. et al. Genomic Analyses Lead to Novel Secondary Metabolites. J Antibiot 59, 533–542 (2006). https://doi.org/10.1038/ja.2006.74
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/ja.2006.74
Keywords
This article is cited by
-
Structural and functional comparison of Saccharomonospora azurea strains in terms of primycin producing ability
World Journal of Microbiology and Biotechnology (2020)
-
Genomic-driven discovery of an amidinohydrolase involved in the biosynthesis of mediomycin A
Applied Microbiology and Biotechnology (2018)
-
New approaches to antibiotic discovery
Biotechnology Letters (2017)
-
Genetics and Genomics of the Genus Amycolatopsis
Indian Journal of Microbiology (2016)
-
Complete genome sequence and comparative genomic analyses of the vancomycin-producing Amycolatopsis orientalis
BMC Genomics (2014)
